VICR vs. SNPS: Which Stock Offers Better Growth Potential?

Vicor (VICR) and Synopsys (SNPS) are benefiting from AI-driven semiconductor growth. VICR reported 45% sequential growth in Advanced Products revenue and expects $600M in 2026 revenue. SNPS saw 42.4% year-over-year revenue growth and raised fiscal 2026 guidance. Both companies show strong growth prospects in the AI and semiconductor sectors.

Original reporting
Published Oct 30, 2026, 3:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 3:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
VICR vs. SNPS: Which Stock Offers Better Growth Potential? — source image
Decision brief

The 30-second read

$VICRBullishMed
01

Why it matters

Both companies are presented as benefiting from AI-driven demand, with Vicor emphasizing Advanced Products growth and licensing royalties, and Synopsys emphasizing recurring revenue, backlog, and raised fiscal guidance.

02

Market read

Traders can use the disclosed quarterly momentum and guidance ranges to update near-term expectations and relative positioning between VICR and SNPS.

03

What to watch

No discussion of customer concentration, competitive intensity in EDA/power conversion, or margin sensitivity to mix and licensing timing, which could moderate the guidance-to-results translation.

Relevance 4/10Novelty 5/10Timing: decision framework for near-term positioning after guidance and quarterly metrics are disclosed

Background

The article compares Vicor (power conversion for AI/data centers) versus Synopsys (EDA, IP, simulation, and Ansys) as AI investment expands semiconductor design and power needs.

Company-level read

Ticker impact

$VICRBullishMedium confidence
Context

Vicor’s Advanced Products revenues rose 45% sequentially to $94.2M in Q2 2026, with backlog up 26% sequentially and licensing royalties accelerating.

Expected impact

Likely upward bias as investors price in continued sequential revenue growth and expanding royalty stream.

Evidence & confidence

The article cites multiple improving demand indicators (Advanced Products mix, book-to-bill above 1, backlog growth) plus a specific licensing agreement expected to add quarterly royalty revenue.

$SNPSBullishHigh confidence
Context

Synopsys raised fiscal 2026 guidance, with Q3 FY2026 revenues up 42.4% and non-GAAP EPS up 15.3%, alongside 82% recurring revenue.

Expected impact

Likely positive reaction bias as the market incorporates raised revenue and earnings guidance and continued AI-driven design complexity demand.

Evidence & confidence

The article provides concrete, company-specific guidance ranges and performance metrics (revenue, EPS, recurring revenue share, backlog) that directly affect near-term expectations.

Market effects

Reinforces AI infrastructure capex read-through for power components (Vicor) and chip design/verification software (Synopsys), supporting broader semicap sentiment.

Primarily US-listed semicap software and components sentiment; limited direct regional spillover described.

AI chip design and power delivery are global themes, but the article’s catalysts are company-specific rather than macro-driven.

Counterpoint

The piece is a comparative valuation and growth-potential framing, so upside may already be priced given large YTD outperformance for Vicor and rich multiples for Synopsys.

Key entities

  • Vicor Corporation

    High-density power-conversion components provider; article highlights Advanced Products growth, backlog strength, and royalty/licensing acceleration.

  • Synopsys Inc.

    EDA software and semiconductor IP provider with Ansys simulation; article highlights recurring revenue, backlog, and raised fiscal 2026 guidance.

  • NVIDIA

    Named as a collaboration reference for Synopsys agentic AI verification improvements.

  • Microsoft

    Named as a collaboration reference for Synopsys agentic AI verification improvements.

  • AMD

    Named as a collaboration reference for Synopsys agentic AI verification improvements.

Related articles

$SNPSMed

Why is Synopsys stock sliding today?

Synopsys (SNPS) stock fell 2.0% to $456.73 after Anthropic's IPO roadshow highlighted AI-driven chip design, raising competition concerns. The stock has declined further from its 52-week high of $539.48, with One Way Holdings LLC reducing its position by 99%. Investors are evaluating Synopsys's valuation and integration risks amid broader market uncertainty.

$SNPSMed

Why Should You Think About Synopsys Differently Now?

Synopsys (SNPS) trades at 80.8x P/E, focusing on AI-driven chip design and Ansys. Its IP business, which underperformed due to export restrictions and customer challenges, returned to growth in Q3 2026. Ansys revenue was 1.5x Design IP's revenue in the same quarter. Management highlights a shift to a licensing-plus-royalties model, with a $1B+ deal with Amazon.

$VICRMed

VICR SWOT Analysis: Strong Revenue Growth and Patent Settlement

Vicor Corp (VICR) reported Q3 2026 revenue of $197.1M, up 78.5% YoY, driven by product sales and royalty revenue. Gross margin increased to 68.3%. The company has a strong order backlog of $406M but faces valuation concerns and customer concentration risks. It has growth opportunities in EVs and renewable energy. VICR's GF Score is 82/100, with high growth and profitability ratings but low valuation.

$VICRHigh

VICR Stock Surges On Blowout Q3 And Aggressive Capacity Bet

Vicor Corporation (VICR) stock rose 12.95% after reporting Q3 2026 revenue of $197.1M, up 78.5% YoY, with gross margin at 68.3%. The company's backlog and operating cash flow increased, driven by AI and high-performance systems demand. VICR is expanding capacity and faces an ITC investigation. Analysts raised price targets to $350-$360.

$SNPSMed

S&P lifts Synopsys to ’BBB+’ as chip-design leader capitalizes on AI demand

S&P Global Ratings upgraded Synopsys Inc's credit rating to 'BBB+' from 'BBB', citing strong long-term growth prospects driven by AI demand. The company expects mid-teens revenue growth through 2029 and improved profitability, with 2029 EBITDA margin projected at 49%. Synopsys is also accelerating cost synergies from its Ansys acquisition and expanding commercial traction, including a $1B+ contract with Amazon.